510(k) Report

510(k) · Cleared

Cleared

iFlash-HCG; Chemiluminescence Immunoassay Analyzer (Model: iFlash 3000-C)

K223690510(k) TraditionalCleared Dec 11, 2023367-day reviewClass II21 CFR 862.1155

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Shenzhen Yhlo Biotech Co., Ltd. · DHA System, Test, Human Chorionic Gonadotropin

Cleared on Dec 11, 2023 as substantially equivalent to K003178 (Roche Diagnostics Corp., 2000) and 1 other predicate after a 367-day review. Its family tree reaches back 3 generations to 1992.

Decided
Dec 11, 2023
Review
367 days
Class
Class II
Product code
DHA
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K915195 (1992). 4 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK915195 Enzymun-Test TSHBoehringer Mannheim Corp. · 1992
  2. 2 generations backK961491 Elecsys TSH AssayBoehringer Mannheim Corp. · 1996
  3. 1 generation backK162606 Elecsys TSH assay, cobas e 801 Immunoassay analyzerRoche Diagnostics · 2017 · Recalled
  4. This deviceK223690 iFlash-HCG; Chemiluminescence Immunoassay Analyzer (Model: iFlash…Shenzhen Yhlo Biotech Co., Ltd. · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K915195Enzymun-Test TSHBoehringer Mannheim Corp.1992—
−2K961491Elecsys TSH AssayBoehringer Mannheim Corp.1996—
−1K162606Elecsys TSH assay, cobas e 801 Immunoassay analyzerRoche Diagnostics20173
0 (this device)K223690iFlash-HCG; Chemiluminescence Immunoassay Analyzer (Model: iFlash 3000-C)Shenzhen Yhlo Biotech Co., Ltd.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010
FIG. 1 — Lineage of K223690, 1992–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DHA device

  1. #1 K233581 VITROS Immunodiagnostic Products Total ß-hCG…score 7.6 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K003178Elecsys HCG and Beta Test System
Summary page 5
…, Test, Human Chorionic Gonadotropin; Analyzer, Chemistry (Photometric, Discrete) for Clinical Use Candidate Device k223690 Predicate Devices k003178, Elecsys HCG+β reagent; k162606, Cobas e 801 analyzer 1 Device Description iFlash-HCG that includes tes…
Roche Diagnostics Corp.2000—
*K162606Elecsys TSH assay, cobas e 801 Immunoassay analyzer
Summary page 5
…Analyzer, Chemistry (Photometric, Discrete) for Clinical Use Candidate Device k223690 Predicate Devices k003178, Elecsys HCG+β reagent; k162606, Cobas e 801 analyzer 1 Device Description iFlash-HCG that includes testing reagents and three levels of calibrators is base…
Roche Diagnostics20173

Also cleared against K003178: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 3 companies; a new generation was cleared every 6.9 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • 1 other device also cites its predicate K003178.

How does its category compare?

All DHA devices

DHA System, Test, Human Chorionic Gonadotropin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · DHA

1in 2024

2007: 22008: 12009: 12013: 22015: 12017: 22019: 12020: 12021: 32022: 12023: 32024: 1
2007high 3 (2021) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHA

63in 2023

2021: 289 days median2023: 63 days median
2007high 289 (2021) · low 63 (2023)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DHA

2in 2022

2010: 22015: 22018: 12022: 2
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHA

234in 2025

2007: 642008: 992009: 1962010: 1792011: 4782012: 2772013: 2442014: 1192015: 522016: 552017: 1012018: 1032019: 1522020: 1152021: 2102022: 1852023: 1942024: 2612025: 234
2007high 478 (2011) · low 52 (2015)2025

MAUDE reports naming product code DHA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—064
20081—099
20091—0196
20100—2179
20110—0478
20120—0277
20132—0244
20140—0119
20151—252
20160—055
20172—0101
20180—1103
20191—0152
20201—0115
202132890210
20221—2185
20233630194
20241—0261
20250—0234
20260—0—

What is it indicated for?

iFlash-HCG is a paramagnetic particle chemiluminescent immunoassay (CLIA) for quantitative detection of the intact human chorionic gonadotropin (hCG) molecule and the hCG β-subunit (β-hCG) in human serum and plasma using the automated Chemiluminescence Immunoassay Analyzer (Model: iFlash 3000-C). The iFlash-HCG assay is to be used by laboratory professionals as an aid in early detection of pregnancy together with other clinical methods. Chemiluminescence…

Read the full statement (113 words)

iFlash-HCG is a paramagnetic particle chemiluminescent immunoassay (CLIA) for quantitative detection of the intact human chorionic gonadotropin (hCG) molecule and the hCG β-subunit (β-hCG) in human serum and plasma using the automated Chemiluminescence Immunoassay Analyzer (Model: iFlash 3000-C). The iFlash-HCG assay is to be used by laboratory professionals as an aid in early detection of pregnancy together with other clinical methods.

Chemiluminescence Immunoassay Analyzer (Model: iFlash 3000-C) is a fully-automated, chemiluminescence immunoassay analyzer intended for quantitative or qualitative determination of analytes in human body fluids taken from clinical settings. It is used together with its supporting chemiluminescence immunoassay reagents. The Chemiluminescence Immunoassay Analyzer (Model: iFlash 3000-C) is intended for use in clinical laboratories.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223690: iFlash-HCG; Chemiluminescence Immunoassay Analyzer (Model: iFlash 3000-C).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K223690

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026